Search for: "In re Clovis Oncology, Inc. Derivative Litigation" Results 1 - 7 of 7
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Observations on Clovis Oncology, Inc. Derivative Litigation
14 Oct 2019, 5:47 am
On October 1, the Delaware Court of Chancery denied a motion to dismiss a Caremark claim in In re Clovis Oncology, Inc. [read post]
The Harvard Law School Corporate Governance Blog - http://blogs.law.harvard.edu/corpgov
Delaware Court of Chancery Again Sustains Oversight Claims
5 Oct 2019, 7:03 am
 In re Clovis Oncology, Inc. [read post]
The Harvard Law School Corporate Governance Blog - http://blogs.law.harvard.edu/corpgov
Caremark claim over flawed drug trial can proceed, but improper stock sales claim falls away
7 Oct 2019, 10:59 am by John Jascob
In the latest example, the court held that, for purposes of a motion to dismiss, a shareholder derivative complaint sufficiently pleaded that Clovis Oncology, Inc. [read post]
Jim Hamilton's World of Securities Regulation - http://jimhamiltonblog.blogspot.com/
Directors may face oversight liability for not properly monitoring key drug’s clinical trial
16 Oct 2019, 10:59 am by Francis Pileggi
The business judgment rule cannot shield Clovis Oncology Inc. [read post]
Delaware Corporate and Commercial Litigation Blog - http://www.delawarelitigation.com/
Three Is Not A Trend: Another Caremark Claim Survives A Motion To Dismiss, But Does Not Reflect A Change In The Law
27 May 2020, 5:19 am
Hughes is now the second decision, after In re Clovis Oncology, Inc. [read post]
The Harvard Law School Corporate Governance Blog - http://blogs.law.harvard.edu/corpgov
Board Committee Charters and ESG Accountability
15 Feb 2023, 9:05 pm by renholding
Barnhill, 212 A.3d 822 (2018). [2] See PWC 2021 Annual Corporate Directors Survey, The Director’s New Playbook: Taking on Change, at 6. [3] See In re Caremark Inc Derivative Litigation, 698 A.2d 959, 970 (Del. [read post]
The CLS Blue Sky Blog - https://clsbluesky.law.columbia.edu/
Katten Discusses Shareholder Litigation Risk in an Unstable Geopolitical Environment
25 May 2022, 9:01 pm by Richard Zelichov and Trevor T. Garmey
  Compare In re NVIDIA Corp. [read post]
The CLS Blue Sky Blog - https://clsbluesky.law.columbia.edu/